epacadostat

• 

Epacadostat plus pembrolizumab combination shows promise in advanced solid tumours

By Sharon Kell|2018-10-09T13:54:16+00:009 Oct 2018|Drug treatments|

Headline results from the open-label phase I/II ECHO-202/KEYNOTE-037 trial assessing [...]

Read More

Comments Off on Epacadostat plus pembrolizumab combination shows promise in advanced solid tumours

Promising new immunotherapy drug for advanced/metastatic kidney cancer

By Sharon Kell|2018-02-28T12:36:10+00:0028 Feb 2018|Drug treatments|

Immunotherapy has revolutionised the treatment of renal cell carcinoma (RCC). [...]

Read More

Comments Off on Promising new immunotherapy drug for advanced/metastatic kidney cancer

• 

Novel treatment options for kidney cancer presented at ASCO 2017

By Sharon Kell|2017-06-15T13:38:32+00:0015 Jun 2017|Drug treatments|

The following video is an interview between PracticeUpdate and Dr Bradley [...]

Read More

Comments Off on Novel treatment options for kidney cancer presented at ASCO 2017

Next generation cancer drugs that boost response to immunotherapy

By Sharon Kell|2017-06-07T14:36:16+00:007 Jun 2017|Drug treatments|

Drugs that target a protein called indoleamine 2,3-dioxygenase (or IDO [...]

Read More

Comments Off on Next generation cancer drugs that boost response to immunotherapy

• 

New drug epacadostat plus pembrolizumab combination shows promise in patients with advanced kidney cancer

By Sharon Kell|2017-06-06T13:22:46+00:006 Jun 2017|Drug treatments|

The results from a phase I/II clinical trial of epacadostat [...]

Read More

Comments Off on New drug epacadostat plus pembrolizumab combination shows promise in patients with advanced kidney cancer